Clinical factors associated with Hydrogen and Methane Breath Testing

  • Research type

    Research Study

  • Full title

    Clinical factors associated with Hydrogen and Methane Breath Testing for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth.

  • IRAS ID

    357338

  • Contact name

    Kelly Hard

  • Contact email

    swbh.randd.sponsorship@nhs.net

  • Sponsor organisation

    SWBH NHS Trust, Research and Development

  • Duration of Study in the UK

    0 years, 4 months, 1 days

  • Research summary

    Hydrogen and Methane breath testing (HMBT) is used to diagnose different conditions, including Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO). This is done by measuring the amount of hydrogen and methane gas in the breath after following pre-test preparation and fasting. For the test a sugar drink is given and then a breath sample is taken periodically, monitoring
    for a significant rise in hydrogen or methane, which would indicate having SIBO. Similarly, a high amount of methane at any time during the test would suggest having IMO.
    Unfortunately, symptoms for SIBO and IMO vary between people, although it has been observed that diarrhoea is related to SIBO and constipation to IMO. Patients are referred for HMBT when they suffer from a wide range of intestinal symptoms, including bloating, nausea, excessive gas, diarrhoea or constipation.
    This project focuses on the relationship between specific symptoms and other existing conditions, such as irritable bowel syndrome (IBS) or previous abdominal surgeries, with the results of HMBT. Patients referred for HMBT will complete two questionnaires asking for common intestinal symptoms, pre-existing conditions and anxiety scores to see the relationship between these and the test results.
    Exploring these relationships of symptoms and pre-existing conditions helps in understanding SIBO and IMO, to help the right patients being referred to appropriate investigations, so they can be treated effectively and alleviate their symptoms.
    The study would help to better understand SIBO and IMO symptoms, and search for other factors that would increase the chances of having these conditions, for more effective investigations and improving referrals.

  • REC name

    East of England - Cambridge East Research Ethics Committee

  • REC reference

    25/EE/0267

  • Date of REC Opinion

    8 Dec 2025

  • REC opinion

    Further Information Favourable Opinion